Skip to main content
MS-DRG 139 · MDC 03 · Surgical

MS-DRG 139: Salivary Gland Procedures

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: IPPS Table 5 (MS-DRG weights): v44 FY2027 (final rule + CN3) (effective October 1, 2026); MS-DRG Definitions Manual: v44 (effective October 1, 2026). Next CMS release: FY2028 final rule (August 2027), effective October 1, 2027; an April 1 interim grouper update when CMS issues one for the IPPS Table 5 (MS-DRG weights); the FY2028 grouper, effective October 1, 2027 for the MS-DRG Definitions Manual.

Key facts for DRG 139

FY2027 relative weight
1.1547
Higher than 30% of all MS-DRGs
Change vs FY2026
-6.6%
FY2026 weight 1.2357
Geometric mean LOS
2.2 days
Arithmetic mean 3.2 days
MDC
03
Diseases and Disorders of the Ear, Nose, Mouth and Throat
Severity level
single severity level
National unadjusted operating payment
$7,907.39
Weight × $6,848.00 FY2027 standardized amount; capital adds $623.48
Transfer policy
Not a transfer DRG

TL;DR

MS-DRG 139 is a surgical group in MDC 03 (Diseases and Disorders of the Ear, Nose, Mouth and Throat), with no CC/MCC severity split. CMS assigns it a FY2027 relative weight of 1.1547 with a geometric mean length of stay of 2.2 days and an arithmetic mean of 3.2. Its weight moved down 6.6% from FY2026 (1.2357). That weight is higher than 30% of all MS-DRGs. The v44 Definitions Manual assigns it through 169 operating room procedures codes.

What changed from FY2026 to FY2027

CMS recalibrates every MS-DRG weight annually from the prior year's MedPAR claims. For DRG 139 the FY2027 relative weight is 1.1547 against 1.2357 in FY2026, a fall of 6.55%, which exceeds the 2% threshold worth re-checking in contract models.

FY2026 versus FY2027 payment factors for MS-DRG 139
MetricFY2026FY2027Change
Relative weight1.23571.1547-0.0810
Geometric mean LOS (days)2.02.2+0.2
Arithmetic mean LOS (days)2.93.2+0.3
Weights shown are the FY2027 final values after the 10% cap on year-over-year reductions where applicable.

CC and MCC family

DRG 139 stands alone: CMS does not split this base group by CC or MCC severity, so complication documentation does not move the assignment, although it still affects quality and risk-adjustment reporting.

National unadjusted payment for DRG 139

Multiplying the FY2027 relative weight (1.1547) by the national rates in IPPS Tables 1A and 1D, as corrected by notice CMS-1849-CN3, gives the base amounts below. This group has no CC/MCC sibling, so the amount does not change with secondary-diagnosis capture.

FY2027 national unadjusted IPPS payment for MS-DRG 139
ComponentNational rateDRG 139
Operating (labor and nonlabor share)$4,519.68 + $2,328.32 = $6,848.00$7,907.39
Capital (federal rate)$539.95$623.48
Operating plus capital$8,530.87
Assumes the full annual update (the hospital submitted quality data and is a meaningful EHR user). A hospital with a reduced update starts from $7,660.04 to $7,845.55 for the operating portion of this DRG.

These are national, unadjusted figures, not what a given hospital is paid. The labor share is multiplied by the hospital's wage index (Table 1A applies when the wage index is above 1.0 and Table 1B otherwise), and teaching (IME), disproportionate share (DSH), outlier, transfer and new-technology add-on rules then change the amount for each stay. Use the figures to compare groups and to size a documentation finding, not to forecast a remittance; the DRG payment calculator applies a hospital's own wage index and teaching and DSH factors to DRG 139.

Grouper logic (v44 Definitions Manual)

Operating Room Procedures: 169 ICD-10-PCS codes in this DRG's assignment logic; the first 12 are shown.

Operating Room Procedures codes in the logic for DRG 139 (sample)
ICD-10-PCS codeDescription
0C580ZZDestruction of Right Parotid Gland, Open Approach
0C583ZZDestruction of Right Parotid Gland, Percutaneous Approach
0C590ZZDestruction of Left Parotid Gland, Open Approach
0C593ZZDestruction of Left Parotid Gland, Percutaneous Approach
0C5B0ZZDestruction of Right Parotid Duct, Open Approach
0C5B3ZZDestruction of Right Parotid Duct, Percutaneous Approach
0C5C0ZZDestruction of Left Parotid Duct, Open Approach
0C5C3ZZDestruction of Left Parotid Duct, Percutaneous Approach
0C5D0ZZDestruction of Right Sublingual Gland, Open Approach
0C5D3ZZDestruction of Right Sublingual Gland, Percutaneous Approach
0C5F0ZZDestruction of Left Sublingual Gland, Open Approach
0C5F3ZZDestruction of Left Sublingual Gland, Percutaneous Approach

Documentation and denial exposure

As a surgical DRG, assignment depends on a qualifying operating-room procedure being coded from the operative report; a missing or non-OR procedure code drops the stay into a medical DRG in MDC 03 with a lower weight. The inpatient claim reports that procedure in ICD-10-PCS, which NCCI does not edit; the surgeon's professional claim for the same operation carries CPT and HCPCS codes, and the NCCI pair checker for those professional codes shows whether two of them bundle. Because this family has no severity split, review risk concentrates on medical-necessity of the admission itself and on the two-midnight benchmark. Typical inpatient denial codes for this group: CARC 16 (claim lacks information needed to group the stay), CARC 50 (the admission or procedure is judged not medically necessary), CARC 97 (a service is bundled into the DRG payment).

For teams evaluating QuickIntell software

Evaluate a documentation and coding workflow for DRG 139

Explore QuickCode for qualified coder review and documentation clarification, or QuickScribe for clinician-reviewed visit documentation. Confirm inpatient scope, the supported grouper version and reviewer responsibilities during evaluation. This public reference is not a production grouper and does not determine a claim's reimbursement.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — DRG 139

What is MS-DRG 139?

MS-DRG 139 is "Salivary Gland Procedures", a surgical Medicare Severity Diagnosis-Related Group in MDC 03 (Diseases and Disorders of the Ear, Nose, Mouth and Throat). Medicare pays inpatient stays grouped here at the hospital's base rate multiplied by the DRG relative weight.

What is the FY2027 relative weight for DRG 139?

The FY2027 relative weight is 1.1547 (IPPS final rule Table 5, effective October 1, 2026). In FY2026 it was 1.2357, a change of -6.6%.

What is the Medicare base payment for MS-DRG 139?

$7,907.39 for operating costs plus $623.48 for capital, $8,530.87 together, at the FY2027 national rates: weight 1.1547 times the $6,848.00 operating standardized amount and the $539.95 capital rate (IPPS Tables 1A and 1D as corrected by CMS-1849-CN3). The hospital's wage index, IME, DSH, outlier and transfer adjustments change what a given stay is paid.

What is the average length of stay for DRG 139?

CMS reports a geometric mean length of stay of 2.2 days and an arithmetic mean of 3.2 days for FY2027. The geometric mean is used for transfer-payment calculations.

What documentation supports the severity level of DRG 139?

DRG 139 has no CC or MCC sibling, so secondary-diagnosis capture does not change the group or its 1.1547 weight. Review effort belongs instead on the principal diagnosis sequencing and the 169 procedure codes that place the stay in this group, and on medical necessity of the inpatient admission itself under the two-midnight benchmark against a 2.2-day geometric mean stay, which is where denials for single-severity groups concentrate.

Which codes group to DRG 139?

The v44 Definitions Manual lists 169 operating room procedures codes for this group. Examples from the operating room procedures list, 0C580ZZ (Destruction of Right Parotid Gland, Open Approach); 0C583ZZ (Destruction of Right Parotid Gland, Percutaneous Approach); 0C590ZZ (Destruction of Left Parotid Gland, Open Approach); 0C593ZZ (Destruction of Left Parotid Gland, Percutaneous Approach).

Is DRG 139 a post-acute transfer DRG?

No. DRG 139 is not on the FY2027 post-acute care transfer list, so the transfer per-diem policy does not apply to it.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from the CMS IPPS FY2027 final rule (Table 5) and the v44 ICD-10 MS-DRG Definitions Manual. Relative weights are national factors; actual payment depends on each hospital's wage-adjusted base rate, add-ons, outliers and transfer adjustments. Nothing here is legal, clinical or billing advice; verify grouping against your encoder and the published CMS files.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.